DRICORT Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Dricort, and what generic alternatives are available?
Dricort is a drug marketed by Ingram Pharm and is included in one NDA.
The generic ingredient in DRICORT is hydrocortisone acetate. There are sixty-seven drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the hydrocortisone acetate profile page.
Summary for DRICORT
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 90 |
Patent Applications: | 3,821 |
Formulation / Manufacturing: | see details |
DailyMed Link: | DRICORT at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for DRICORT
US Patents and Regulatory Information for DRICORT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ingram Pharm | DRICORT | hydrocortisone acetate | LOTION;TOPICAL | 086207-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |